摘要
黑色素瘤抑制活性(MIA)蛋白质被恶性黑素瘤细胞强烈表达和分泌,并显示出促进黑素瘤的发生和侵袭。MIA蛋白是第一个细胞外蛋白,显示在溶液中可以结合纤连蛋白III型结构域的Src同源3(SH3)结构域样折叠。与MIA一起,同源蛋白OTOR(或FDP),MIA-2和TANGO(或MIA-3)构成非胞质的蛋白质家族,除了全长TANGO和TANGO1样(TALI) - 细胞外SH3- 含有蛋白质的结构域。蛋白质家族的成员调节胶原成熟和出口,软骨发育,细胞外基质中的细胞附着和黑素瘤转移。因此,这些蛋白质可以用作针对恶性黑素瘤的药物开发的有希望的靶标。 在过去二十年中,NMR光谱已经成为药物化学中的有力技术。虽然传统的高通量筛选仅报告了低分子化合物的活性或亲和力,NMR光谱不仅涉及具有其活性的那些化合物的结构,而且还可以解开蛋白上配体结合位点的结构信息 原子分辨率。基于配体与其靶蛋白之间的相互作用的分子细节,可以更有效地进一步改进初始片段命中的结合亲和力,以产生具有显着疗效的铅结构。基于NMR的方法有望大大有助于寻求低分子量化合物,最终可以产生药物以更有效地治疗皮肤相关疾病如恶性黑素瘤。
关键词: NMR
Current Medicinal Chemistry
Title:NMR-based Drug Development and Improvement Against Malignant Melanoma – Implications for the MIA Protein Family
Volume: 24 Issue: 17
关键词: NMR
摘要: The Melanoma Inhibitory Activity (MIA) protein is strongly expressed and secreted by malignant melanoma cells and was shown to promote melanoma development and invasion. The MIA protein was the first extracellular protein shown to adopt an Src homology 3 (SH3) domain-like fold in solution that can bind to fibronectin type III domains. Together with MIA, the homologous proteins OTOR (or FDP), MIA-2, and TANGO (or MIA-3) constitute a protein family of non-cytosolic and – except for fulllength TANGO and TANGO1-like (TALI) – extracellular SH3-domain containing proteins. Members of this protein family modulate collagen maturation and export, cartilage development, cell attachment in the extracellular matrix, and melanoma metastasis. These proteins may thus serve as promising _targets for drug development against malignant melanoma.
For the last twenty years, NMR spectroscopy has become a powerful technique in medicinal chemistry. While traditional high throughput screenings only report on the activity or affinity of low molecular weight compounds, NMR spectroscopy does not only relate to the structure of those compounds with their activity, but it can also unravel structural information on the ligand binding site on the protein at atomic resolution. Based on the molecular details of the interaction between the ligand and its _target protein, the binding affinities of initial fragment hits can be further improved more efficiently in order to generate lead structures that exhibit significant therapeutic effects. The NMR-based approach promises to greatly contribute to the quest for low molecular weight compounds that ultimately could yield drugs to treat skin-related diseases such as malignant melanoma more effectively.Export Options
About this article
Cite this article as:
NMR-based Drug Development and Improvement Against Malignant Melanoma – Implications for the MIA Protein Family, Current Medicinal Chemistry 2017; 24 (17) . https://dx.doi.org/10.2174/0929867324666170608104347
DOI https://dx.doi.org/10.2174/0929867324666170608104347 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: Personalized Cancer Treatment)
Current Molecular Pharmacology lGnRH-III - a Promising Candidate for Anticancer Drug Development
Protein & Peptide Letters Meta Analysis of Advanced Cancer Survival Data Using Lognormal Parametric Fitting: A Statistical Method to Identify Effective Treatment Protocols
Current Pharmaceutical Design LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic _target in Patients with Tumor Diseases
Current Drug _targets Duloxetine in the Treatment of Depression: An Overview
Central Nervous System Agents in Medicinal Chemistry Remote Ischemic Conditioning Improves Cognitive Function During Cerebral Vascular Injury Through the Induction of Autophagy
Current Neurovascular Research Advanced Methods for the Analysis of Testosterone
Current Medicinal Chemistry Antitumor and Antioxidant Activities of the New Synthesized Azomethine Derivatives: Experimental and Theoretical Investigations
Letters in Organic Chemistry Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies C-11 Radiochemistry in Cancer Imaging Applications
Current Topics in Medicinal Chemistry An Emerging Therapeutic Approach by _targeting Myoferlin (MYOF) for Malignant Tumors
Current Topics in Medicinal Chemistry Molecular _targets of FTY720 (Fingolimod)
Current Molecular Medicine Understanding the Molecular Properties and Metabolism of Top Prescribed Drugs
Current Topics in Medicinal Chemistry Synthetic and Natural Polycations for Gene Therapy: State of the Art and New Perspectives
Current Gene Therapy Virus-Like Particles as Particulate Vaccines
Current HIV Research Antiangiogenic Therapy
Current Pharmaceutical Design Pleiotropic Role of HSF1 in Neoplastic Transformation
Current Cancer Drug _targets Modulators of Vascular Sex Hormone Receptors and their Effects in Estrogen-Deficiency States Associated with Menopause
Recent Patents on Cardiovascular Drug Discovery Recent Advance in the Research of Flavonoids as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Functions of MAPR (Membrane-Associated Progesterone Receptor) Family Members As Heme/Steroid-Binding Proteins
Current Protein & Peptide Science